Breaking News - The Fly

Open Search

MBIO

Mustang Bio

$

()

Mustang Bio announces vision for CAR T-Cell therapy platform expansion

MBIO

3/28/2024 - 09:10am

Mustang Bio files to sell common stock, warrants, no amount given

MBIO

3/15/2024 - 17:26pm

Mustang Bio announces publication of data from Phase 1 trial of MB-101

MBIO

3/7/2024 - 07:34am

Mustang Bio files to sell 2.74M shares of common stock for holders

MBIO

12/12/2023 - 06:05am

Mustang Bio presents updated Phase 1/2 data for MB-106

MBIO

12/11/2023 - 08:48am

Mustang Bio to present MB-106 CD20-targeted CAR-T data

MBIO

11/2/2023 - 09:29am

Mustang Bio sells 2.59M shares at $1.70 in registered direct offering

MBIO

10/26/2023 - 12:33pm

Mustang Bio announces FDA acceptance of IND application for MB-109

MBIO

10/26/2023 - 09:06am

option delistings on September 25th

PHIO , OBLG , NYC

…

9/25/2023 - 08:30am

Mustang announces first data from ongoing multicenter Phase 1/2 trial of MB-106

MBIO

8/16/2023 - 08:20am

Mustang Bio price target lowered to $16 from $20 at BTIG

MBIO

8/15/2023 - 08:40am

Mustang Bio reports Q2 EPS ($2.00), consensus ($1.81)

MBIO

8/14/2023 - 16:43pm

Mustang Bio amends, closes manufacturing partnership transaction with uBriGene

MBIO

7/31/2023 - 08:53am

Mustang Bio price target raised to $20 from $4 at BTIG

MBIO

6/16/2023 - 09:24am

Mustang Bio announces final data from follicular lymphoma cohort of MB-106 trial

MBIO

6/15/2023 - 16:07pm